• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number C40+
Device Problems Circuit Failure (1089); Output Problem (3005)
Patient Problems Failure of Implant (1924); Tinnitus (2103); Dizziness (2194)
Event Date 09/17/2019
Event Type  Injury  
Manufacturer Narrative
The device has been explanted and has been returned to innsbruck where it will be evaluated.When available, a device failure analysis will be submitted as a follow-up report.
 
Event Description
The user is reported to be a successful user of the device.On (b)(6) 2019 the user reported headaches and tinnitus and a beeping sensation from the device.In situ testing done at that time was unremarkable.The user denies any trauma and there is no report of changes in health.The device has been explanted.
 
Event Description
The user is reported to be a successful user of the device.On (b)(6) 2019 the user reported headaches and tinnitus and a beeping sensation from the device.In situ testing done at that time was unremarkable.The user denies any trauma and there is no report of changes in health.
 
Manufacturer Narrative
Conclusion: device investigation confirmed that the stimulator electronics failed.The failure of the electronic circuitry was probably caused by humidity ingress at detected micro-leaks at the housing braze joint.Other damages found during investigation are most likely related to explantation surgery.In addition the recipient reported dizziness and tinnitus when using the device, which are known post-operative side effects of otologic surgery.These symptoms are also present with the new device.The problems described in the recipient report appear to match the damage found.This is a final report.
 
Event Description
The user is reported to be a successful user of the device.On (b)(6) 2019 the user reported headaches and tinnitus and a beeping sensation from the device.In situ testing done at that time was unremarkable.The user denies any trauma and there is no report of changes in health.The user was re-implanted.
 
Manufacturer Narrative
Conclusion: device investigation confirmed that the stimulator electronics failed.The failure of the electronic circuitry was probably caused by humidity ingress at detected micro-leaks at the housing braze joint.Other damages found during investigation are most likely related to explantation surgery.The problems described in the recipient report appear to match the damage found.This is a final report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM
Type of Device
COCHLEAR IMPLANT
Manufacturer (Section D)
MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
innsbruck
AU 
MDR Report Key9672337
MDR Text Key177831140
Report Number9710014-2020-00083
Device Sequence Number1
Product Code MCM
Combination Product (y/n)N
PMA/PMN Number
P000025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberC40+
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/04/2020
Was the Report Sent to FDA? No
Date Manufacturer Received10/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-